A67.1 Intermediate lesions of pinta

Name of the Condition

• Intermediate lesions of pinta

Summary

Intermediate lesions of pinta represent a stage in the chronic skin infection caused by Treponema carateum. These lesions follow the primary stage and are characterized by progressive skin changes, including discoloration, scaling, and textural alterations. The condition affects exposed areas of the body and progresses through distinct phases, with intermediate lesions marking a transition toward late-stage changes.

Causes

Intermediate lesions of pinta result from infection with Treponema carateum, a spirochete bacterium. Transmission occurs through direct skin-to-skin contact with an infected individual, typically in environments with poor hygiene and limited healthcare access. The bacterium invades the skin, leading to the characteristic lesions of this stage.

Risk Factors

• Living in or traveling to endemic tropical regions (e.g., parts of Central and South America).
• Prolonged exposure to infected individuals without protective measures.
• Limited access to healthcare and hygiene resources.

Symptoms

• Discoloration: Hyperpigmentation or hypopigmentation of affected skin.
• Scaling and thickening of lesions.
• Atrophy or textural changes in the skin.
• Progression from primary lesions to more pronounced skin alterations.

Diagnosis

Diagnosis is based on clinical presentation, including the characteristic skin lesions and history of exposure. Laboratory confirmation may involve dark-field microscopy or serologic testing, though these are less commonly used in routine practice.

Treatment Options

• Antibiotics: Penicillin or tetracycline derivatives are typically used to target the bacterium.
• Topical treatments: May be applied to manage skin symptoms and promote healing.
• Monitoring: Regular follow-up to assess lesion progression and response to therapy.

Prognosis and Follow-Up

With appropriate treatment, intermediate lesions of pinta generally improve, though residual discoloration or textural changes may persist. Follow-up is recommended to monitor for progression to late-stage changes or complications. Early intervention can help minimize long-term skin alterations.

Complications

• Persistent skin discoloration or scarring.
• Progression to late-stage lesions with more severe textural changes.
• Psychological impact due to visible skin alterations.

Lifestyle & Prevention

• Avoid direct skin-to-skin contact with infected individuals.
• Practice good hygiene, especially in endemic areas.
• Seek prompt medical care if skin lesions develop after potential exposure.

When to Seek Professional Help

Consult a healthcare provider if skin lesions appear, especially after travel to endemic regions, or if existing lesions worsen or spread. Early diagnosis and treatment can prevent progression to advanced stages.

Tips for Medical Coders

Document the clinical stage (e.g., intermediate) and characteristic skin findings to support code assignment. Ensure documentation aligns with the progression of pinta and differentiates this stage from primary or late lesions. Note any associated symptoms or treatment responses for comprehensive coding.